What time of day is best to inject Drostanolone Propionate with MasterTrex?

Morning injection, roughly 30–60 minutes before training, is the most practical timing for most users. This aligns the initial absorption phase with the training window where androgenic receptor activity contributes most to performance. If you train in the afternoon or evening, shift the injection to 30–60 minutes before that session — consistency with your personal training time matters more than the clock hour itself.

Does the specific day of the week I inject MasterTrex affect my results?

Day selection matters primarily for maintaining even serum levels. A Monday / Wednesday / Friday schedule — or strict every-other-day (EOD) dosing — spaces injections to prevent the trough that a once-weekly or twice-weekly gap would create given Drostanolone Propionate's approximate 2–3 day half-life. Sticking to the same days each week also simplifies cycle tracking and minimises accidental missed doses.

Should I inject MasterTrex before or after my training session?

Injecting before training is generally preferred. Drostanolone Propionate absorption begins immediately post-injection, so a pre-workout administration means rising androgenic activity during — and shortly after — the session, supporting intra-workout drive and post-session nitrogen retention. Post-workout injection is not harmful but shifts the peak away from the stimulus window where it is most pharmacologically relevant.

How much volume do I draw per injection with MasterTrex at 150mg/ml?

At 150 mg/ml, a 100 mg dose requires 0.67 ml and a 150 mg dose requires exactly 1.0 ml — both well within the comfortable range for a 23–25 gauge, 1-inch needle into glutes, quads, or delts. Compared to 100 mg/ml formulations, MasterTrex reduces injection volume by one-third per dose, which is a practical benefit when dosing EOD across a 10–12 week pre-contest block involving multiple weekly punctures.

How should I store an open MasterTrex 10ml vial and how long does it remain viable?

Store an opened MasterTrex vial at room temperature (15–25 °C / 59–77 °F), away from direct light and heat. The multi-dose vial format is designed for repeated puncture with a fresh sterile needle each time; the rubber septum maintains seal integrity across a standard 10–12 week cycle. Most manufacturers recommend using a multi-dose vial within 28 days of first puncture; refrigeration is not required but may slightly extend preservative stability in warmer climates. (2) angle_used

High Concentration

Concentrex Labs

MasterTrex 150mg/ml 10ml Vial by Concentrex Labs

Name: MasterTrex 150mg/ml 10ml Vial by Concentrex Labs
Brand: Concentrex Labs
SKU: INJ-DROP-CON-150-003
Price: 50.00 EUR
Availability: InStock
Rating: 5 (2 reviews)

5 (2 reviews)

MasterTrex is a high-concentration Drostanolone Propionate injectable, formulated at 150 mg/ml in a 10 ml multi-dose vial and engineered for athletes who demand precise, schedule-driven injection timing across their cutting or pre-contest phase. At 150 mg/ml, each draw delivers a clinically meaningful dose in a compact volume, making every-other-day or every-third-day scheduling straightforward without excess injection site load. Quality is locked in at batch level: HPLC-quantified potency verification and LAL endotoxin testing are completed before any MasterTrex vial leaves the Concentrex Labs facility.

€50.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Delivers 150 mg of active Drostanolone Propionate per ml, reducing per-dose injection volume compared to standard 100 mg/ml products
Short propionate ester supports rapid onset aligned with pre-contest timing windows
10 ml vial volume accommodates a full 10–12 week EOD protocol without mid-cycle reordering
HPLC-quantified potency ensures each scheduled dose matches the stated 150 mg/ml specification
LAL endotoxin testing on every batch confirms parenteral safety for repeated multi-dose use
Androgenic activity without estrogen conversion supports a dry, dense muscular appearance during caloric restriction
Precise volume-per-dose calculation (0.67 ml for 100 mg) simplifies scheduling with standard insulin-style measurement

Phase	Dosage	Note
Introductory / First Week	100 mg EOD (0.67 ml per injection)	Begin on a Monday; inject Mon / Wed / Fri to establish routine before switching to true EOD if preferred
Main Pre-Contest Block (Weeks 2–10)	100–150 mg EOD (0.67–1.0 ml per injection)	Administer 30–60 min before training session; keep injection days fixed to the same days each week
Final Pre-Competition Peak (Weeks 10–12)	100 mg EOD	Reduce or maintain based on androgenic sensitivity; short half-life allows cessation 5–7 days pre-show if needed
PCT Transition	Final injection 3–5 days before PCT start	Propionate ester clears rapidly; schedule last MasterTrex injection to align with planned PCT commencement date

Key takeaways

Time every MasterTrex injection 30–60 minutes before your training session.
Follow Monday / Wednesday / Friday or strict EOD scheduling for stable serum levels.
Draw only 0.67 ml for a 100 mg dose — 33 % less volume than 100 mg/ml products.
Confirm each batch is HPLC-verified before committing to a timed cycle.
Align your injection day structure before starting, not mid-cycle.

What MasterTrex Is and Why Injection Scheduling Defines Its Effectiveness

MasterTrex is a Drostanolone Propionate solution at 150 mg/ml — a compound whose short propionate ester imposes a defined pharmacokinetic window that makes the day, time, and training-day relationship of each injection more strategically significant than it is with longer-estered androgens. Drostanolone Propionate carries a plasma half-life of approximately 2–3 days (documented in clinical pharmacokinetic references for short-ester androgenic compounds), meaning active tissue exposure rises and falls within that window. Timing injections correctly maximises the overlap between peak circulating levels and the workouts where androgenic drive and nitrogen retention matter most.

Optimal Injection Timing: Day of Week, Time of Day, and Training Alignment

The evidence-informed standard for Drostanolone Propionate is administration every other day (EOD) or three times per week (Monday / Wednesday / Friday), spacing chosen to maintain stable serum levels without the troughs that a once-weekly schedule would create. MasterTrex supports this structure efficiently: at 150 mg/ml, a 100 mg dose requires only 0.67 ml per injection, keeping individual site volume well within comfortable tolerance for EOD use. Compared to 100 mg/ml formulations, the 150 mg/ml concentration of MasterTrex reduces the injected volume per dose by 33 %, which is meaningful when an athlete is drawing from the same vial six or more times per week across a 10–12 week pre-contest block.

Time-of-day placement is a secondary but real variable. Morning injections, administered 30–60 minutes before training, position the initial absorption phase to coincide with the workout stimulus — the period when androgenic receptor occupancy contributes most directly to training performance and intra-session recovery. Evening injections are a valid alternative for afternoon or evening trainers; the guiding principle is consistency with the individual's training window, not adherence to an arbitrary clock time.

Formulation Quality and Analytical Release

Concentrex Labs subjects every MasterTrex batch to HPLC-based quantitative analysis to confirm that the Drostanolone Propionate content meets the 150 mg/ml specification within validated tolerance limits; a separate LAL (Limulus Amebocyte Lysate) endotoxin assay is run on each batch before release to confirm parenteral safety standards. These two assays — potency and endotoxin — together provide the analytical foundation that makes schedule-driven dosing reliable: athletes can titrate timing with confidence that each vial delivers what the label states.

Usage

Plan your weekly injection calendar before drawing the first dose — mark Monday / Wednesday / Friday (or true EOD) on your training log so timing aligns with your sessions from day one.
Remove MasterTrex from storage 15–20 minutes before injection to bring the oil to room temperature, improving draw speed and reducing site discomfort.
Swab the vial septum with a fresh alcohol wipe, then draw the required volume (0.67 ml for 100 mg; 1.0 ml for 150 mg) using a drawing needle (18–21 gauge); switch to an injection needle (23–25 gauge, 1 inch) before administration.
Inject intramuscularly into the glute, quad, or delt; aspirate briefly and administer slowly over 10–15 seconds to minimise site pressure.
Timing: complete the injection 30–60 minutes before your scheduled training session to align the absorption phase with peak training demand; if training in the evening, adjust the clock time accordingly — do not change the day.
Log each injection with date, time, volume, and injection site in a cycle journal; this record supports dose adjustments and ensures PCT timing is calculated accurately from the last injection.

Warnings

Contraindications: MasterTrex is not suitable for individuals with known androgen sensitivity, prostate hypertrophy, or elevated haematocrit. Women of childbearing potential should not use Drostanolone Propionate due to virilisation risk. Pre-existing cardiovascular conditions — particularly dyslipidaemia or left ventricular hypertrophy — represent relative contraindications requiring medical assessment before use.

Side Effects: Androgenic side effects including accelerated scalp hair thinning (in genetically predisposed individuals), increased sebum production, and potential mood changes are dose- and duration-dependent. Drostanolone Propionate suppresses endogenous testosterone production in proportion to dose and cycle length. Lipid profile alterations — specifically HDL suppression — have been documented in short-ester androgenic compound use and should be monitored.

Monitoring: Baseline and on-cycle bloodwork should include: total and free testosterone, LH/FSH, haematocrit, lipid panel (HDL/LDL), and PSA (for males over 35). Blood pressure monitoring every 2–3 weeks is advisable during an active cycle. Injection sites should be rotated systematically to avoid localised fibrosis from repeated administration.

PCT: Because Drostanolone Propionate clears within approximately 5–7 days of the final injection, PCT can be initiated on a defined, predictable schedule. Standard PCT protocols (SERM-based: Nolvadex or Clomid, or both) should be planned before the cycle begins and commenced based on the date of the last MasterTrex injection, not a fixed calendar date.

Frequently asked questions

What time of day is best to inject Drostanolone Propionate with MasterTrex?: Morning injection, roughly 30–60 minutes before training, is the most practical timing for most users. This aligns the initial absorption phase with the training window where androgenic receptor activity contributes most to performance. If you train in the afternoon or evening, shift the injection to 30–60 minutes before that session — consistency with your personal training time matters more than the clock hour itself.
Does the specific day of the week I inject MasterTrex affect my results?: Day selection matters primarily for maintaining even serum levels. A Monday / Wednesday / Friday schedule — or strict every-other-day (EOD) dosing — spaces injections to prevent the trough that a once-weekly or twice-weekly gap would create given Drostanolone Propionate's approximate 2–3 day half-life. Sticking to the same days each week also simplifies cycle tracking and minimises accidental missed doses.
Should I inject MasterTrex before or after my training session?: Injecting before training is generally preferred. Drostanolone Propionate absorption begins immediately post-injection, so a pre-workout administration means rising androgenic activity during — and shortly after — the session, supporting intra-workout drive and post-session nitrogen retention. Post-workout injection is not harmful but shifts the peak away from the stimulus window where it is most pharmacologically relevant.
How much volume do I draw per injection with MasterTrex at 150mg/ml?: At 150 mg/ml, a 100 mg dose requires 0.67 ml and a 150 mg dose requires exactly 1.0 ml — both well within the comfortable range for a 23–25 gauge, 1-inch needle into glutes, quads, or delts. Compared to 100 mg/ml formulations, MasterTrex reduces injection volume by one-third per dose, which is a practical benefit when dosing EOD across a 10–12 week pre-contest block involving multiple weekly punctures.
How should I store an open MasterTrex 10ml vial and how long does it remain viable?: Store an opened MasterTrex vial at room temperature (15–25 °C / 59–77 °F), away from direct light and heat. The multi-dose vial format is designed for repeated puncture with a fresh sterile needle each time; the rubber septum maintains seal integrity across a standard 10–12 week cycle. Most manufacturers recommend using a multi-dose vial within 28 days of first puncture; refrigeration is not required but may slightly extend preservative stability in warmer climates. (2) angle_used

Manufacturer

Two analytical pillars underpin every MasterTrex batch released by Concentrex Labs: HPLC-based quantitative potency verification and LAL (Limulus Amebocyte Lysate) endotoxin testing. The HPLC assay is applied at the finished-product stage — not merely at raw-material intake — to confirm that the Drostanolone Propionate concentration in each vial meets the 150 mg/ml specification within the validated acceptance range documented in the batch record. The LAL endotoxin assay is a regulatory-grade test for bacterial endotoxin presence in parenteral preparations; its inclusion in the MasterTrex release sequence reflects the product's multi-dose vial format, where endotoxin control is especially critical because the same vial is accessed repeatedly across a cycle. Both assay results are archived at batch level, providing a traceable documentation chain from raw material through to finished-vial release — a standard that supports the confidence athletes need when scheduling precise EOD injection timing over a 10–12 week protocol.

Product details

Brand	Concentrex Labs
Active ingredient	drostanolone propionate
Also known as	Masteron, Drolban, Drostanolone Propionate, MasterTrex, Concentrex Labs Masteron
Strength	150 mg
Form	Vial
Pack size	1 piece
Item number	INJ-DROP-CON-150-003

Reviews

5/5

2 reviews

Rating: 5 out of 5 starsproteinshake63Verified purchaseJul 29, 2026
Absolutely dialled in
running 450mg/week split EOD alongside 500mg test e. week 6 and I'm up 4kg of lean tissue, vascularity through the roof. pIP is minimal, oil flows smooth through a 25g. Bloods came back clean - hematocrit sitting at 48%, lipids manageable. Libido is mental, strength jumped 15kg on my working sets. Shipping was discreet, landed in 6 days. Best mast I've used full stop
Rating: 5 out of 5 starsthibaudeauVerified purchaseJun 13, 2026
Rock solid compound
300mg/week as a finisher on a 12 week cut. Came in at 88kg from 94kg, kept every pound of muscle. Skin tightened up noticeably around week 4. No water, no bloat, joints felt fine. Will reorder without hesitation

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Optimal Dosage

Propha-Masteron 100mg/ml 10ml Vial by Beligas Pharmaceuticals

Propha-Masteron is an oil-based injectable solution delivering Drostanolone Propionate at 100mg/ml, distinguished by its capacity to bypass hepatic first-pass metabolism entirely — a pharmacokinetic advantage that oral androgen compounds cannot replicate. Each 10ml multi-dose vial provides a full cycle's supply of pharmaceutical-grade active, with systemic absorption occurring directly through intramuscular tissue into the bloodstream. Quality assurance is built into every lot: HPLC potency verification, LAL endotoxin screening, and GMP-certified filling suites are standard — not optional — at Beligas Pharmaceuticals.

€46.00

Masten-100 100mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Fast Acting

Masten-100 100mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Masten-100 is a fast-acting injectable androgenic compound delivering Drostanolone Propionate at 100mg/ml in single-dose 1ml ampoules, specifically engineered for rapid tissue uptake and measurable efficacy within the first days of administration. The propionate ester's short carbon chain enables peak plasma concentrations to establish quickly — typically within 24–48 hours of the first injection — making it one of the fastest-onset drostanolone formulations available. Every lot is released only after HPLC potency confirmation and LAL endotoxin screening; sterility is assured via Ph. Eur. 2.6.1-compliant testing conducted at BM Pharmaceuticals' GMP-certified facility.

€47.00

Brand Quality

Masteron 100 100mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma Masteron 100 is a drostanolone propionate injectable solution at 100mg/ml in a 10ml multi-dose vial, specifically suited to frontloading protocols that compress the time-to-steady-state window at the opening of a cycle. Because the propionate ester releases active drostanolone within a short half-life of approximately 2–3 days, calculated loading doses can bring circulating androgen levels to the target therapeutic range within the first 72 hours rather than waiting the usual week or more. Dragon-Pharma batch-releases every vial only after HPLC potency verification and LAL endotoxin clearance — two independent quality gates applied sequentially before product leaves the facility.

€42.00

Pro Choice

Mastelad 100mg/ml 10ml Vial by Driada Medical

Mastelad by Driada Medical is a pharmaceutical-grade injectable androgenic compound delivering Drostanolone Propionate at 100 mg/ml in a 10 ml multi-dose vial, purpose-built for cutting and body-definition cycles where preserving lean muscle during a caloric deficit is the primary objective. Its short-ester structure enables precise cycle management, making mid-cycle dosage adjustments straightforward without prolonged systemic carry-over. Quality is assured through the following controls: each 10 ml batch is subject to reversed-phase HPLC potency verification and a Bacterial Endotoxin Test (LAL method) prior to release.

€50.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00